Purpose Interstitial cystitis/painful bladder syndrome (IC/PBS) is a chronic pain syndrome and a chronic inflammatory condition prevalent in women that leads to urgency, sleep disruption, nocturia and pain in the pelvic area, to the detriment of the suffererâs quality of life. The aim of this review is to highlight the newest diagnostic strategies and potential therapeutic techniques. Methods A comprehensive literature review was performed on MEDLINE, PubMed, and Cochrane databases gathering all literature about âInterstitial cystitisâ and âPainful Bladder Syndromeâ. Visual analogue scales, epidemiological strategies, pain questionnaires and similar techniques were not included in this literature survey. Results The etiology, exact diagnosis and epidemiology of IC/PBS are still not clearly understood. To date, its prevalence is estimated to be in the range of 45 per 100,000 women and 8 per 100,000 men, whereas joint prevalence in both sexes is 10.6 cases per 100,000. There are no âgold standardsâ in the diagnosis or detection of IC/PBS, therefore, several etiological theories were investigated, such as permeability, glycosaminoglycans, mast cell, infection and neuroendocrine theory to find new diagnostic strategies and potential biomarkers. Conclusion Due to the fact that this disease is of an intricate nature, and that many of its symptoms overlap with other concomitant diseases, it could be suggested to classify the patients with emphasis on the phenotype, as well as their symptom clusters, to tailor the diagnostic and management choices according to the observed biomarkers.
|Titolo:||Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome|
|Data di pubblicazione:||2017|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|Etiology, pathophysiology and biomarkers of interstitial cystitispainful bladder syndrome.pdf||Full text articolo in rivista||Versione Editoriale (PDF)||Administrator|